 Risperidone
"Risperidone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
| Descriptor ID |
D018967
|
| MeSH Number(s) |
D03.383.742.698.685
|
| Concept/Terms |
R-64,766- R-64,766
- R 64,766
- R64,766
- R-64766
- R 64766
- R64766
|
Below are MeSH descriptors whose meaning is more general than "Risperidone".
Below are MeSH descriptors whose meaning is more specific than "Risperidone".
This graph shows the total number of publications written about "Risperidone" by people in UAMS Profiles by year, and whether "Risperidone" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 1 | 0 | 1 | | 2016 | 1 | 0 | 1 | | 2015 | 1 | 1 | 2 | | 2014 | 1 | 1 | 2 | | 2013 | 1 | 1 | 2 | | 2011 | 1 | 0 | 1 | | 2010 | 0 | 1 | 1 | | 2007 | 0 | 2 | 2 | | 2006 | 1 | 0 | 1 | | 2004 | 2 | 0 | 2 | | 2003 | 1 | 1 | 2 | | 1999 | 1 | 0 | 1 | | 1998 | 0 | 1 | 1 | | 1995 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Risperidone" by people in Profiles over the past ten years.
-
Wilson MP, Nordstrom K, Hopper A, Porter A, Castillo EM, Vilke GM. Risperidone in the Emergency Setting is Associated with More Hypotension in Elderly Patients. J Emerg Med. 2017 Nov; 53(5):735-739.
-
An T, Choi J, Kim A, Lee JH, Nam Y, Park J, Sun Bk, Suh H, Kim CJ, Hwang SJ. Sustained release of risperidone from biodegradable microspheres prepared by in-situ suspension-evaporation process. Int J Pharm. 2016 Apr 30; 503(1-2):8-15.
-
Aman M, Rettiganti M, Nagaraja HN, Hollway JA, McCracken J, McDougle CJ, Tierney E, Scahill L, Arnold LE, Hellings J, Posey DJ, Swiezy NB, Ghuman J, Grados M, Shah B, Vitiello B. Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial. J Child Adolesc Psychopharmacol. 2015 Aug; 25(6):482-93.
-
Bloomfield K, Pulliam E, Schultz E, Ward WL. Russian Adoption: A Case Study With Mixed Clinical Presentation. Clin Pediatr (Phila). 2015 Oct; 54(11):1123-4.
-
Jensen PS. TOSCA: no longer just an opera. J Am Acad Child Adolesc Psychiatry. 2014 Sep; 53(9):938-41.
-
Wilson MP, Minassian A, Bahramzi M, Campillo A, Vilke GM. Despite expert recommendations, second-generation antipsychotics are not often prescribed in the emergency department. J Emerg Med. 2014 Jun; 46(6):808-13.
-
Weiss MD. Review: Limited evidence that risperidone reduces aggression and conduct problems in the short term in children and adolescents with disruptive behaviour disorders. Evid Based Ment Health. 2013 Aug; 16(3):69.
-
Ghate SR, Porucznik CA, Said Q, Hashibe M, Joy E, Brixner DI. Association between second-generation antipsychotics and changes in body mass index in adolescents. J Adolesc Health. 2013 Mar; 52(3):336-43.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|